Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Phone650-493-4000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.92 billion
Profitability
Miscellaneous
Employees7,174
OptionableOptionable
Varian Medical Systems (NYSE:VAR) Frequently Asked Questions
What is Varian Medical Systems' stock symbol?
Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."
How were Varian Medical Systems' earnings last quarter?
Varian Medical Systems, Inc. (NYSE:VAR) posted its earnings results on Wednesday, January, 23rd. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.07 by $0.01. The medical equipment provider earned $741 million during the quarter, compared to analyst estimates of $717.83 million. Varian Medical Systems had a net margin of 12.28% and a return on equity of 26.18%. The business's quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.06 earnings per share. View Varian Medical Systems' Earnings History.
When is Varian Medical Systems' next earnings date?
What guidance has Varian Medical Systems issued on next quarter's earnings?
Varian Medical Systems updated its FY19 earnings guidance on Wednesday, January, 23rd. The company provided earnings per share guidance of $4.60-4.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.73. The company issued revenue guidance of $3.06-$3.15 billion, compared to the consensus revenue estimate of $3.11 billion.Varian Medical Systems also updated its FY 2019 guidance to $4.60-4.75 EPS.
What price target have analysts set for VAR?
9 brokers have issued 1-year price objectives for Varian Medical Systems' stock. Their forecasts range from $105.00 to $145.00. On average, they anticipate Varian Medical Systems' share price to reach $128.4286 in the next twelve months. This suggests that the stock has a possible downside of 3.2%. View Analyst Price Targets for Varian Medical Systems.
What is the consensus analysts' recommendation for Varian Medical Systems?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Varian Medical Systems.
What are Wall Street analysts saying about Varian Medical Systems stock?
Here are some recent quotes from research analysts about Varian Medical Systems stock:
- 1. According to Zacks Investment Research, "Varian ended the first quarter of fiscal 2019 on a strong note with earnings meeting estimates and revenues beating the same. Varian continues to gain from core Oncology Segment, which saw solid overseas growth in the quarter. Strength in China buoys optimism. In fact, management foresees tremendous opportunities in China for Varian’s radiation therapy products. Meanwhile, the company’s flagship Halcyon system was granted exclusion from Section 301 tariffs. Additionally, new proton therapy products are building momentum for Varian’s Proton Solutions business. The stock has outperformed the industry in a year’s time. On the flip side, Varian’s gross and operating margins contracted in the quarter. The U.S.-China tariffs also impacted the top line, denting income from the Oncology segment. Varian competes with large electronic companies as well as smaller and more specialized radiation therapy equipment manufacturers." (1/26/2019)
- 2. Barrington Research analysts commented, "We are maintaining our OUTPERFORM investment rating on VAR shares and are increasing our price target to $135 from our previous $132. We arrive at our price target by attaching a 17.5x multiple to our adjusted EBITDA estimate for FY/19. We assume $800 million in net cash 12 months from now." (1/24/2019)
- 3. BTIG Research analysts commented, "For its fiscal first quarter, Varian again outperformed on two key metrics: revenue and Oncology gross orders. Revenue of $741.0M topped consensus by ~$20M while Oncology gross orders of $716.5M was ~$60M above estimates. We like that Oncology gross order growth of +17% y/y CC was the highest in a decade and that the strength came from all regions. Still, with VAR shares trading near all-time historical highs, investors were likely seeking perfection. VAR may trade up Thursday, but with gross margins and operating margins coming in below consensus models, we think the positive stock reaction may be just a few dollars." (1/24/2019)
Has Varian Medical Systems been receiving favorable news coverage?
Media stories about VAR stock have trended neutral on Saturday, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Varian Medical Systems earned a coverage optimism score of 0.2 on InfoTrie's scale. They also gave headlines about the medical equipment provider a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future.
Who are some of Varian Medical Systems' key competitors?
Some companies that are related to Varian Medical Systems include SONOVA HLDG AG/ADR (SONVY), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), NxStage Medical (NXTM), Natus Medical (BABY), Viewray (VRAY), AxoGen (AXGN), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Semler Scientific (SMLR), Cutera (CUTR), Helius Medical Technologies (HSDT) and Electrocore (ECOR).
Who are Varian Medical Systems' key executives?
Varian Medical Systems' management team includes the folowing people:
- Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
- Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
- Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
- Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
- Mr. Patrick Joda, Sr. VP of Global Operations (Age 61)
Who are Varian Medical Systems' major shareholders?
Varian Medical Systems' stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.97%), Fiera Capital Corp (2.93%), Bank of America Corp DE (1.82%), Alecta Pensionsforsakring Omsesidigt (1.52%), Northern Trust Corp (1.42%) and Geode Capital Management LLC (1.39%). Company insiders that own Varian Medical Systems stock include David J Illingworth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.
Which major investors are selling Varian Medical Systems stock?
VAR stock was sold by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, Commonwealth Bank of Australia, BlackRock Inc., Alecta Pensionsforsakring Omsesidigt, Mackay Shields LLC, D. E. Shaw & Co. Inc., Canada Pension Plan Investment Board and Bank of Nova Scotia. Company insiders that have sold Varian Medical Systems company stock in the last year include David J Illingworth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.
Which major investors are buying Varian Medical Systems stock?
VAR stock was bought by a variety of institutional investors in the last quarter, including Polar Capital LLP, California Public Employees Retirement System, Citigroup Inc., Geode Capital Management LLC, DNB Asset Management AS, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Two Sigma Investments LP and Madison Investment Holdings Inc.. View Insider Buying and Selling for Varian Medical Systems.
How do I buy shares of Varian Medical Systems?
Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Varian Medical Systems' stock price today?
One share of VAR stock can currently be purchased for approximately $132.74.
How big of a company is Varian Medical Systems?
Varian Medical Systems has a market capitalization of $12.05 billion and generates $2.92 billion in revenue each year. The medical equipment provider earns $149.90 million in net income (profit) each year or $4.42 on an earnings per share basis. Varian Medical Systems employs 7,174 workers across the globe.
What is Varian Medical Systems' official website?
How can I contact Varian Medical Systems?
Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]
MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe VAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
